» Articles » PMID: 1315417

Specific Low-affinity Recognition of Major Histocompatibility Complex Plus Peptide by Soluble T-cell Receptor

Overview
Journal Nature
Specialty Science
Date 1992 Apr 30
PMID 1315417
Citations 56
Authors
Affiliations
Soon will be listed here.
Abstract

The T-cell receptor is necessary and sufficient for recognition of peptides presented by major histocompatibility complex molecules. Other adhesion molecules, like CD4 or CD8, play an auxiliary role in antigen recognition by T cells. Here we analyse T-cell receptor (TCR) binding using a soluble rather than a cell-bound receptor molecule. A TCR-immunoglobulin chimaera is constructed with the variable and the first constant regions of both the TCR alpha- and beta-chains linked to the immunoglobulin light-chain constant regions. This soluble TCR is expressed, assembled and secreted as an alpha beta heterodimer by a myeloma cell line transfected with the recombinant genes. Furthermore, the soluble TCR is biologically active: it specifically inhibits antigen-dependent activation of the relevant T-cell clones and thus discriminates between proper and irrelevant peptides presented by major histocompatibility complex molecules.

Citing Articles

CRISPR-Cas9 screening reveals a distinct class of MHC-I binders with precise HLA-peptide recognition.

Schoufour T, van der Plas-van Duijn A, Derksen I, Melgers M, van Veenendaal J, Lensen C iScience. 2024; 27(6):110120.

PMID: 38939106 PMC: 11209011. DOI: 10.1016/j.isci.2024.110120.


Triple-negative breast cancer: A run-through of features, classification and current therapies.

Manjunath M, Choudhary B Oncol Lett. 2021; 22(1):512.

PMID: 33986872 PMC: 8114477. DOI: 10.3892/ol.2021.12773.


Optogenetic Tuning of Ligand Binding to The Human T cell Receptor Using The opto-ligand-TCR System.

Yousefi O, Horner M, Wess M, Idstein V, Weber W, Schamel W Bio Protoc. 2021; 10(5):e3540.

PMID: 33659514 PMC: 7842703. DOI: 10.21769/BioProtoc.3540.


T Cell Activation Machinery: Form and Function in Natural and Engineered Immune Receptors.

Chandler N, Call M, Call M Int J Mol Sci. 2020; 21(19).

PMID: 33050044 PMC: 7582382. DOI: 10.3390/ijms21197424.


Targeting cancers through TCR-peptide/MHC interactions.

He Q, Jiang X, Zhou X, Weng J J Hematol Oncol. 2019; 12(1):139.

PMID: 31852498 PMC: 6921533. DOI: 10.1186/s13045-019-0812-8.